Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Konstantinos Kostikas, Katerina Dimakou, Konstantinos Gourgoulianis, Mina Gaga, Dimosthenis Papapetrou, Georgios Tsoukalas, Panagiotis Chatziapostolou, Antonios Antoniadis, Georgios Meletis, Efstathia Evangelopoulou, Panagiota Styliara, Ilektra Karypidou, Athena Gogali, Konstantinos Kalafatakis & Nikolaos Tzanakis. (2022) A Real-World Study on the Day and Night-Time Symptoms Among Greek COPD Patients Who Recently Initiated Treatment with Dual Bronchodilation: The DANICO Study. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2027-2041.
Read now
Read now
Maud Koopman, Frits M E Franssen, Swetlana Gaffron, Henrik Watz, Thierry Troosters, Judith Garcia-Aymerich, Pierluigi Paggiaro, Eduard Molins, Miguel Moya, Lindy van Burk, Dieter Maier, Esther Garcia Gil, Emiel F M Wouters, Lowie E G W Vanfleteren & Martijn A Spruit. (2022) Differential Outcomes Following 4 Weeks of Aclidinium/Formoterol in Patients with COPD: A Reanalysis of the ACTIVATE Study. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 517-533.
Read now
Read now
Maria Gabriella Matera, Barbara Rinaldi, Carmela Belardo & Mario Cazzola. (2022) Pharmacotherapy of LAMA/LABA inhaled therapy combinations for chronic obstructive pulmonary disease: a clinical overview. Expert Review of Clinical Pharmacology 15:11, pages 1269-1281.
Read now
Read now
Fiammetta Danzo, Dejan Radovanovic, Marina Gatti, Marina Saad, Luca Perotto, Elisa Franceschi & Pierachille Santus. (2022) A reappraisal of inspiratory capacity in chronic obstructive pulmonary disease: clinical correlates and role of long-acting muscarinic antagonists and long-acting β2 agonists. Expert Review of Respiratory Medicine 16:6, pages 623-635.
Read now
Read now
Anthony D. D’Urzo, Dave Singh, James F. Donohue, Kenneth R. Chapman & Robert A. Wise. (2021) Aclidinium bromide/formoterol fumarate as a treatment for COPD: an update. Expert Review of Respiratory Medicine 15:9, pages 1093-1106.
Read now
Read now
Koichiro Takahashi, Masaru Uchida, Go Kato, Ayako Takamori, Takashi Kinoshita, Makoto Yoshida, Ryo Tajiri, Keisuke Kojima, Hiroshi Inoue, Hiromi Kobayashi, Hironori Sadamatsu, Hiroki Tashiro, Masahide Tanaka, Shinichiro Hayashi, Atsushi Kawaguchi, Shinya Kimura, Naoko Sueoka-Aragane & Tomotaka Kawayama. (2020) First-Line Treatment with Tiotropium/Olodaterol Improves Physical Activity in Patients with Treatment-Naïve Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2115-2126.
Read now
Read now
Stefan Andreas, Ulrich Bothner, Alberto de la Hoz, Isabel Kloer, Matthias Trampisch & Peter Alter. (2020) A Post Hoc Holter ECG Analysis of Olodaterol and Formoterol in Moderate-to-Very-Severe COPD. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1955-1965.
Read now
Read now
Trija Vaidya, Véronique Thomas-Ollivier, François Hug, Alain Bernady, Camille Le Blanc, Claire de Bisschop & Arnaud Chambellan. (2020) Translation and Cultural Adaptation of PROactive Instruments for COPD in French and Influence of Weather and Pollution on Its Difficulty Score. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 471-478.
Read now
Read now
Ryan Haley, Nita Gupta & Sanjay Sethi. (2020) Aclidinium bromide and formoterol fumarate for the maintenance treatment of chronic obstructive pulmonary disease. Expert Review of Clinical Pharmacology 13:2, pages 103-113.
Read now
Read now
Jean Bourbeau, Mohit Bhutani, Paul Hernandez, Shawn D. Aaron, Meyer Balter, Marie-France Beauchesne, Anthony D’Urzo, Roger Goldstein, Alan Kaplan, François Maltais, Don D. Sin & Darcy D. Marciniuk. (2019) Canadian Thoracic Society Clinical Practice Guideline on pharmacotherapy in patients with COPD – 2019 update of evidence. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 3:4, pages 210-232.
Read now
Read now
Sanjay Sethi, Edward Kerwin, Henrik Watz, Gary T Ferguson, Robert M Mroz, Rosa Segarra, Eduard Molins, Diana Jarreta & Esther Garcia Gil. (2019) AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 667-682.
Read now
Read now
Wilfried De Backer, Jan De Backer, Wim Vos, Ilse Verlinden, Cedric Van Holsbeke, Johan Clukers, Bita Hajian, Shahid Siddiqui, Martin Jenkins, Colin Reisner & Ubaldo J Martin. (2018) A randomized study using functional respiratory imaging to characterize bronchodilator effects of glycopyrrolate/formoterol fumarate delivered by a metered dose inhaler using co-suspension delivery technology in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2673-2684.
Read now
Read now
Masakazu Ichinose, Yoshiaki Minakata, Takashi Motegi, Jun Ueki, Yasuhiro Gon, Tetsuo Seki, Tatsuhiko Anzai, Shuhei Nakamura & Kazuto Hirata. (2018) Efficacy of tiotropium/olodaterol on lung volume, exercise capacity, and physical activity. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1407-1419.
Read now
Read now
Articles from other publishers (37)
Yoshiaki Minakata, Yuichiro Azuma, Seigo Sasaki & Yusuke Murakami. (2023) Objective Measurement of Physical Activity and Sedentary Behavior in Patients with Chronic Obstructive Pulmonary Disease: Points to Keep in Mind during Evaluations. Journal of Clinical Medicine 12:9, pages 3254.
Crossref
Crossref
Laura Delgado-Ortiz, Ashley Polhemus, Alison Keogh, Norman Sutton, Werner Remmele, Clint Hansen, Felix Kluge, Basil Sharrack, Clemens Becker, Thierry Troosters, Walter Maetzler, Lynn Rochester, Anja Frei, Milo A Puhan & Judith Garcia-Aymerich. (2023) Listening to the patients’ voice: a conceptual framework of the walking experience. Age and Ageing 52:1.
Crossref
Crossref
Marc Miravitlles, Juan Luís García-Rivero, Xavier Ribera, Jordi Galera, Alejandra García, Rosa Palomino & Xavier Pomares. (2022) Exercise capacity and physical activity in COPD patients treated with a LAMA/LABA combination: a systematic review and meta-analysis. Respiratory Research 23:1.
Crossref
Crossref
Hironobu Hamada, Kiyokazu Sekikawa, Ken Okusaki, Takefumi Dodo, Kazuyoshi Kagawa, Tatsuya Sumigawa, Yoshikazu Awaya, Naoki Sakimoto, Sachiko Shioya, Keisuke Hakozaki, Toru Kadowaki, Maki Kakimoto, Ryoji Ito, Koji Kawamichi, Keiichi Kondo, Haruchi Namba, Hiroshi Iwamoto & Noboru Hattori. (2022) Hochuekkito Combined with Pulmonary Rehabilitation in Apathetic Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Pilot Trial. Journal of Clinical Medicine 11:19, pages 5673.
Crossref
Crossref
Henrik Watz. (2022) Körperliche Aktivität bei chronisch obstruktiver Lungenerkrankung – jeder Schritt zähltPhysical activity in chronic obstructive pulmonary disease—Every step counts. Der Pneumologe 19:3, pages 164-168.
Crossref
Crossref
Cassie Rist, Niklas Karlsson, Sofia Necander & Carla A. Da Silva. (2022) Physical activity end-points in trials of chronic respiratory diseases: summary of evidence. ERJ Open Research 8:1, pages 00541-2021.
Crossref
Crossref
Chris Burtin, Divya Mohan, Thierry Troosters, Henrik Watz, Nicholas S. Hopkinson, Judith Garcia-Aymerich, Marilyn L. Moy, Ioannis Vogiatzis, Harry B. Rossiter, Sally Singh, Debora D. Merrill, Alan Hamilton, Stephen I. Rennard, Malin Fageras, Stefano Petruzzelli, Ruth Tal-Singer, Erin Tomaszewski, Solange Corriol-Rohou, Carolyn L. Rochester, Frank C. Sciurba, Richard Casaburi, William D.-C. Man, Rob C. Van Lummel, Christopher B. Cooper, Heleen Demeyer, Martijn A. Spruit & Anouk Vaes. (2021) Objectively Measured Physical Activity as a COPD Clinical Trial Outcome. Chest 160:6, pages 2080-2100.
Crossref
Crossref
Thomas M. Siler, Claire Hohenwarter, Kuangnan Xiong, Kenneth Sciarappa, Shahin Sanjar & Sanjay Sharma. (2021) Efficacy of Nebulized Glycopyrrolate on Lung Hyperinflation in Patients with COPD. Pulmonary Therapy 7:2, pages 503-516.
Crossref
Crossref
Judith Garcia-Aymerich, Milo A Puhan, Solange Corriol-Rohou, Corina de Jong, Heleen Demeyer, Fabienne Dobbels, Damijan Erzen, Anja Frei, Elena Gimeno-Santos, Nicholas S Hopkinson, Nathalie Ivanoff, Niklas Karlsson, Zafeiris Louvaris, Michael I Polkey, Roberto A Rabinovich, Mario Scuri, Maggie Tabberer, Ioannis Vogiatzis & Thierry Troosters. (2021) Validity and responsiveness of the Daily- and Clinical visit-PROactive Physical Activity in COPD (D-PPAC and C-PPAC) instruments. Thorax 76:3, pages 228-238.
Crossref
Crossref
Ellen Tufvesson, Finn Radner, Anton Simonsen, Georgia Papapostolou, Linnea Jarenbäck, Saga Jönsson, Ulf Nihlen, Alf Tunsäter, Jaro Ankerst, Stefan Peterson, Leif Bjermer & Göran Eriksson. (2021)
A new protocol for exercise testing in COPD; improved prediction algorithm for
W
MAX
and validation of the endurance test in a placebo-controlled double bronchodilator study
. Therapeutic Advances in Respiratory Disease 15, pages 175346662110374.
Crossref
Crossref
Nicolle J. Domnik, Matthew D. James, Robin E. Scheeren, Grace A. Ayoo, Sarah M. Taylor, Amanda T. Di Luch, Kathryn M. Milne, Sandra G. Vincent, Devin B. Phillips, Amany F. Elbehairy, Sophie J. Crinion, Helen S. Driver, J. Alberto Neder & Denis E. O’Donnell. (2021) Deterioration of Nighttime Respiratory Mechanics in COPD. Chest 159:1, pages 116-127.
Crossref
Crossref
Yoshiaki Minakata & Seigo Sasaki. (2020) Data Reproducibility and Effectiveness of Bronchodilators for Improving Physical Activity in COPD Patients. Journal of Clinical Medicine 9:11, pages 3497.
Crossref
Crossref
Alexander G. Mathioudakis, Jørgen Vestbo & Dave Singh. (2020) Long-Acting Bronchodilators for Chronic Obstructive Pulmonary Disease. Clinics in Chest Medicine 41:3, pages 463-474.
Crossref
Crossref
Afroditi K. Boutou, Antreas Zafeiridis, Georgia Pitsiou, Konstantina Dipla, Ioannis Kioumis & Ioannis Stanopoulos. (2020) Cardiopulmonary exercise testing in chronic obstructive pulmonary disease: An update on its clinical value and applications. Clinical Physiology and Functional Imaging 40:4, pages 197-206.
Crossref
Crossref
Ruben Buendia, Halsey Lea, Bo Zhang, Jesper Havsol, Faisal M. Khan, Henrik Sillen & Glynn Dennis. (2020) Assessment of Objectively Measured Physical Activity as an Independent Estimator of Functional Status in Clinical Trials. Assessment of Objectively Measured Physical Activity as an Independent Estimator of Functional Status in Clinical Trials.
Angela T Burge, Narelle S Cox, Michael J Abramson & Anne E Holland. (2020) Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD). Cochrane Database of Systematic Reviews.
Crossref
Crossref
Duc Ha & Andrew L. Ries. (2020) Characterization of Dyspnea in Veteran Lung Cancer Survivors Following Curative-Intent Therapy. Journal of Cardiopulmonary Rehabilitation and Prevention 40:2, pages 120-127.
Crossref
Crossref
S N Avdeev, Z R Aisanov, A S Belevsky, K M Beeh, A A Vizel, S K Zyryanov, G L Ignatova, K Kostikas, I V Leshchenko, S I Ovcharenko, A I Sinopal’nikov, O N Titova & E I Shmelev. (2020) The concept of chronic obstructive pulmonary disease clinical control as a decision - making tool in real clinical practice for optimizing of basic pharmacotherapy. Terapevticheskii arkhiv 92:1, pages 89-95.
Crossref
Crossref
Florin Mihaltan, Yochai Adir, Adam Antczak, Konstantinos Porpodis, Vesna Radulovic, Nuno Pires, Geeuwke Jan de Vries, Andreas Horner, Samuel De Bontridder, Yunqin Chen, Anat Shavit, Silviu Alecu & Lukasz Adamek. (2019) Importance of the relationship between symptoms and self-reported physical activity level in stable COPD based on the results from the SPACE study. Respiratory Research 20:1.
Crossref
Crossref
Nancy A. Dreyer, Ana Filipa Macedo & Priscilla Velentgas. 2019. Pharmacoepidemiology. Pharmacoepidemiology
342
354
.
Thierry Troosters, Astrid Blondeel, Fernanda M. Rodrigues, Wim Janssens & Heleen Demeyer. (2019) Strategies to Increase Physical Activity in Chronic Respiratory Diseases. Clinics in Chest Medicine 40:2, pages 397-404.
Crossref
Crossref
Denis E. O’Donnell, Matthew D. James, Kathryn M. Milne & J. Alberto Neder. (2019) The Pathophysiology of Dyspnea and Exercise Intolerance in Chronic Obstructive Pulmonary Disease. Clinics in Chest Medicine 40:2, pages 343-366.
Crossref
Crossref
S N Avdeev & N V Trushenko. (2019) New opportunities of dual bronchodilation therapy for patients with chronic obstructive pulmonary disease. Terapevticheskii arkhiv 91:3, pages 76-85.
Crossref
Crossref
Usman Maqsood, Terence N Ho, Karen Palmer, Fiona JR Eccles, Mohammed Munavvar, Ran Wang, Iain Crossingham & David JW Evans. (2019) Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2019:3.
Crossref
Crossref
Anthony D. D’Urzo, Dave Singh, James F. Donohue & Kenneth R. Chapman. (2019) Aclidinium bromide in fixed-dose combination with formoterol fumarate in the management of COPD: an update on the evidence base. Therapeutic Advances in Respiratory Disease 13, pages 175346661985072.
Crossref
Crossref
Eric Derom, Guy G. Brusselle & Guy F. Joos. (2019) The once-daily fixed-dose combination of olodaterol and tiotropium in the management of COPD: current evidence and future prospects. Therapeutic Advances in Respiratory Disease 13, pages 175346661984342.
Crossref
Crossref
Han Ni, Soe Moe, Zay Soe, Kay Thi Myint & K Neelakantan Viswanathan. (2018) Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD). Cochrane Database of Systematic Reviews 2018:12.
Crossref
Crossref
Denis E. O’Donnell. (2018) Increasing Physical Activity in Chronic Obstructive Pulmonary Disease One Step at a Time. American Journal of Respiratory and Critical Care Medicine 198:8, pages 977-978.
Crossref
Crossref
Thierry Troosters, François Maltais, Nancy Leidy, Kim L. Lavoie, Maria Sedeno, Wim Janssens, Judith Garcia-Aymerich, Damijan Erzen, Dorothy De Sousa, Lawrence Korducki, Alan Hamilton & Jean Bourbeau. (2018) Effect of Bronchodilation, Exercise Training, and Behavior Modification on Symptoms and Physical Activity in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 198:8, pages 1021-1032.
Crossref
Crossref
A. A. Vizel & I. Yu. Vizel. (2018) 12-Hour fixed-dose combination of andrenergic agonist and cholinergic antagonist in a new administration device: analytical review. Medical Council:15, pages 116-122.
Crossref
Crossref
Takanobu Shioya, Susumu Sato, Masahiro Iwakura, Hitomi Takahashi, Yoshino Terui, Sachiko Uemura & Masahiro Satake. (2018) Improvement of physical activity in chronic obstructive pulmonary disease by pulmonary rehabilitation and pharmacological treatment. Respiratory Investigation 56:4, pages 292-306.
Crossref
Crossref
Denis E. O'Donnell, Amany F. Elbehairy, Danilo C. Berton, Nicolle J. Domnik, Katherine A. Webb & J. Alberto Neder. 2018. Clinical Exercise Testing. Clinical Exercise Testing
235
250
.
Christina Ott. (2018) Das Zeitalter der dualen Bronchodilatation. Pneumo News 10:2, pages 57-57.
Crossref
Crossref
Steven D. Deas & Nikhil Huprikar. (2018) Dual bronchodilator therapy for chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine 24:2, pages 130-137.
Crossref
Crossref
Sunny Jabbal & Brian J. Lipworth. (2017) Sensitivity of Lung Resistance and Compliance to Beta-Blocker Induced Bronchoconstriction and Long Acting Beta-Agonist Withdrawal in COPD. Lung 196:1, pages 15-18.
Crossref
Crossref
Seiko Miyamoto, Yoshiaki Minakata, Yuichiro Azuma, Kazumi Kawabe, Hideya Ono, Ryuta Yanagimoto & Tadatoshi Suruda. (2018) Verification of a Motion Sensor for Evaluating Physical Activity in COPD Patients. Canadian Respiratory Journal 2018, pages 1-8.
Crossref
Crossref
Beate Fessler. (2017) Therapie bringt Plus von 731 Schritten/Tag. Pneumo News 9:7, pages 52-52.
Crossref
Crossref